Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
Trusted Information Creator
Certified November 2025
{arrow_up} Back to top

Rimmyrah 10 mg/ml solution for injection {equilateral_black_triangle}

Active Ingredient:
ranibizumab
Company:  
Orion Pharma (UK) Limited See contact details
ATC code: 
S01LA04
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials Letters to HCPs Audio/Video
{arrow_left}
{arrow_right}
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine.
{info_black}
Last updated on emc: 30 Jul 2024

{equilateral_black_triangle} This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information.

{pdf} View or print the patient leaflet as PDF
Orion Pharma (UK) Limited
Company image
Address
9th Floor, The Blade, Abbey Square, Reading, RG1 3BE, UK
Telephone
+44 (0)1635 520 300
Medical Information e-mail
[email protected]
Out of Hours Telephone
+44 (0)1635 520 300
Adverse event reporting email
[email protected]
Stock Availability
orionukar&[email protected]
WWW
https://www.orionpharma.co.uk